In 1993, it was first reported that PBMCs in newly diagnosed SLE patients produced more IL-10 than healthy control group46, and serum IL-10 was significantly associated with lupus disease activity and anti-ds-DNA titers47. Here, IL10 is linked to systemic lupus erythematosus.